Aoife Brennan - Insider Trading & Ownership

Entity
Individual
Location
200 Sidney Street, Suite 320, C/O Synlogic, Inc., Cambridge, MA
Summary
The estimated net worth of Aoife Brennan is at least $2.15M dollars as of June 27, 2024. Aoife Brennan is the President and CEO, Director of Eliem Therapeutics, Inc. and owns shares of Climb Bio, Inc. (CLYM) stock worth about $1.98M. Aoife Brennan is the President and CEO, Director of SYNLOGIC, INC. and owns shares of SYNLOGIC, INC. (SYBX) stock worth about $148K. Aoife Brennan is the Director of FIBROGEN INC and owns shares of FIBROGEN INC (FGEN) stock worth about $21.2K.
All Insider Reports
All Insider Reports

Ownership of Aoife Brennan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CLYM Climb Bio, Inc. President and CEO, Director $1.98M Jun 27, 2024
SYBX SYNLOGIC, INC. President and CEO, Director $148K Nov 10, 2023
FGEN FIBROGEN INC Director $21.2K Jun 5, 2024
XLO Xilio Therapeutics, Inc. Director Jun 13, 2024

Insider Transactions Reported by Aoife Brennan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.